FMC Corporation (FMC) — ESG & Values Scores

Environment story

FMC faces material environmental headwinds. The company discloses Scope 1 & 2 emissions management but provides limited granular Scope 3 disclosure relative to a chemical manufacturer with global supply chains sourcing from China and India. The company's net-zero target year is not explicitly disclosed in the 10-K, creating ambiguity (deduction applied per rubric). FMC acknowledges climate transition risks and has published a Climate Transition Plan, but the document emphasizes regulatory and market risks rather than demonstrable operational decarbonization infrastructure investments. The company reports phasing out Highly Hazardous Pesticides (HHPs) to 0.1% of sales by 2025, a positive operational step. However, manufacturing hazardous chemicals inherently poses environmental liability; the 10-K discloses extensive environmental compliance obligations and residual liabilities from prior facility use. No evidence of major environmental fines or resource-consumption controversies in 2024–2025, but regulatory uncertainty around PFAS definitions and pesticide re-registration creates ongoing compliance risk.

Criticisms on file

Scope 3 emissions disclosure incomplete; supply-chain carbon footprint from sourcing in China and India not quantified in 10-K.
Source: FMC 10-K Risk Factors and MD&A; company sources raw materials and finished goods primarily from China and India.
Net-zero target year not explicitly stated in 10-K; creates regulatory and credibility ambiguity.
Source: FMC 10-K 2025; sustainability report referenced but target date not disclosed in primary filing.
Regulatory uncertainty around PFAS definitions (EPA vs. OECD) creates product restriction and litigation risk; unquantified compliance costs.
Source: FMC 10-K Risk Factors, Item 1A: 'Varying definitions in regulations create regulatory uncertainty...PFAS...may cause restrictions or bans on certain products.'
Environmental liability from prior facility use; residual contamination risk at acquired properties.
Source: FMC 10-K Risk Factors: 'We are also exposed to residual risk because some of the facilities and land which we have acquired may have environmental liabilities arising from their prior use.'

Disclosed initiatives

Climate Transition Plan & Sustainability Reporting

FMC publishes annual sustainability report and CDP disclosures; utilizes scenario analyses aligned with TCFD and Taskforce on Nature-related Financial Disclosures frameworks.

Demonstrates governance structure for climate risk integration; does not directly reduce emissions.
Highly Hazardous Pesticides (HHP) Phase-Out

HHPs reduced to 0.1% of total sales in 2025 through internal evaluation, monitoring and phase-out processes.

Operational reduction in hazardous product portfolio; supports product stewardship.
Product Sustainability Assessment Tool

Evaluates sustainability attributes of new active ingredients in R&D pipeline; integrated into product development strategy.

Forward-looking stewardship; no disclosed quantitative emissions reduction impact.

Social story

FMC demonstrates solid baseline social performance with low injury rates and union engagement discipline. The company reports ~5,500 employees globally with no material collective-bargaining work stoppages in recent history. Safety culture is evidenced by a Total Recordable Incident Rate (TRIR) of 0.1491, placing FMC in the top decile of peer companies in North America. However, leadership diversity data is not disclosed in the 10-K; CEO-to-worker pay ratio is undisclosed. The company operates in high-risk jurisdictions (China, India) with sourcing of chemicals and raw materials; supply-chain labor compliance audits and human-rights due diligence are not detailed. Talent retention and succession planning are mentioned as strategic priorities; executive compensation structures (performance-based direct pay, long-term incentives) are described but quantitative ratios are absent. India commercial-business divestiture (announced July 2025, expected 2026) may indicate operational challenges but does not explicitly signal labor violations.

Criticisms on file

Leadership diversity (executive and board) not disclosed in 10-K; unable to assess against 30% threshold.
Source: FMC 10-K 2025; executive officer bios provided but no demographic diversity breakdown.
CEO-to-median-worker pay ratio not disclosed; inability to assess compensation equity.
Source: FMC 10-K 2025; executive compensation structure described but ratio metric absent.
Supply-chain labor audits in high-risk jurisdictions (China, India) not detailed; cobalt or lithium mining exposure not quantified.
Source: FMC 10-K sourcing disclosure: 'We source critical intermediates and finished products from a number of suppliers, largely outside of the U.S. and principally in China and India'; no supply-chain human-rights audit disclosure.
India commercial business divestiture approved July 2025; underlying labor or operational challenges not specified, but may signal regional workforce disruption.
Source: FMC 10-K 2025, Item 1A Risk Factors: 'In July 2025, the Board of Directors approved a plan to divest the Company's commercial business in India in response to ongoing commercial challenges in the country.'

Disclosed initiatives

Safety Culture & TRIR Performance

TRIR of 0.1491 (2025); top decile performance in North America peer group; fostered through open reporting culture and continuous improvement processes.

Demonstrably low injury rates; injury-free workplace target embedded in core values.
Talent Development & Retention Programs

Individual development plans, stretch projects, rotational assignments, on-demand learning platform, leadership development and executive coaching.

Supports employee skill development and retention; no quantitative impact metrics disclosed.
Competitive Compensation & Total Rewards

Performance-based direct pay (base, short-term, long-term incentives); comprehensive global benefit packages.

Supports attraction and retention; no disclosed ratio data (e.g., CEO-to-median-worker) for benchmarking.
Inclusive Culture & Employee Engagement Survey

All-employee engagement survey captures voice of workforce; designed to sustain inclusive environment.

Cultural signal; no quantitative diversity or inclusion metrics disclosed.

Governance story

FMC exhibits material governance deficits, primarily driven by recent credit-rating downgrades and covenant amendments signaling financial distress. The company operates a unitary board structure with no disclosed dual-class share structure; board independence percentage is not explicitly stated in the 10-K (deduction applied per rubric for transparency gap). Lobbying expenditures are not disclosed in the filing, preventing assessment against the rubric threshold. The company faces significant regulatory and litigation risk: non-investment-grade credit ratings were downgraded in recent months by major agencies; Amendment No. 5 to the Revolving Credit Facility (December 2025) introduced restrictive covenants and a lien trigger on substantially all assets if public debt ratings fall below BB+ (S&P/Fitch) or Ba1 (Moody's). Patent enforcement litigation is active and ongoing (Sharda USA, Albaugh, Atticus cases in 2024–2025), with mixed outcomes; FMC has secured some favorable judgments and settlements but also experienced patent challenges and reversals (e.g., China Patent Review Board invalidation of intermediate and process patents in 2022–2023, upheld on appeal). No antitrust or SEC consent decrees are disclosed in the current 10-K, but the company underwent strategic review announced February 2026, creating near-term governance uncertainty and potential for shareholder litigation.

Criticisms on file

Board independence percentage not disclosed in 10-K; inability to assess against 75% benchmark.
Source: FMC 10-K 2025; board composition not detailed with independence classifications.
Lobbying expenditures not disclosed; inability to assess alignment with climate/regulatory lobbying standards.
Source: FMC 10-K 2025; no lobbying spend or trade-association alignment statement included.
Credit-rating downgrades below investment grade by major agencies (S&P, Moody's, Fitch) in recent months; triggered Amendment No. 5 covenant package with asset lien triggers.
Source: FMC 10-K 2025, Item 1A Risk Factors: 'In recent months, our long-term credit ratings were downgraded below investment grade by the major rating agencies...The Company entered into Amendment No. 5 to our Revolving Credit Facility in December 2025, which includes certain restrictive covenants and guarantees.'
Patent enforcement litigation ongoing with mixed outcomes; China Patent Review Board invalidated key intermediate and process patents (2022–2023); appeals exhausted and patents expired; Sharda USA preliminary injunction overturned; Atticus case settled with competitor freedom to commercialize.
Source: FMC 10-K 2025, Patents, Trademarks and Licenses section; China IP Court decisions 2023; Sharda case filing June 2024, TRO overturned; Atticus settlement October 2025.
Strategic review process announced February 2026 exploring partnerships, joint ventures, mergers, acquisitions, or licensing; creates near-term uncertainty, potential shareholder litigation, and employee retention risk.
Source: FMC 10-K 2025, Item 1A Risk Factors: 'In February 2026, we announced that the Company is engaging in a strategic review to explore options to enhance shareholder value...the process of reviewing alternative strategic paths could negatively impact our ability to attract, retain and motivate employees, and expose us to potential litigation.'
Dividend significantly reduced beginning January 2026; shareholders not guaranteed future dividend payments per Board discretion.
Source: FMC 10-K 2025, Item 1A Risk Factors: 'Beginning with the dividends paid in January 2026, the Board of Directors significantly reduced the quarterly dividend per share.'

Disclosed initiatives

Climate Transition Risk Governance

Board oversight of climate-related risks and opportunities; scenario analyses and integration into long-term planning per TCFD framework.

Demonstrates governance structure; does not reduce scoring given regulatory compliance framing.
Succession Planning & Senior Management Development

Ongoing succession planning process for CEO and senior management; executive officers listed with tenure and background.

Stated commitment to continuity; no quantitative metrics or disclosed succession triggers.
Compliance & Ethics Programs

Policies mandating compliance with FCPA, anti-bribery, export control, and data privacy regulations; NIST Cybersecurity Framework alignment.

Foundational governance; no disclosed violations or enforcement actions in 2025.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of FMC Corporation. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open FMC Corporation in the app for interactive charts and portfolio building.

More in Basic Materials

Linde plc (LIN) Southern Copper Corporation (SCCO) Newmont Corporation (NEM) Freeport-McMoRan Inc. (FCX) The Sherwin-Williams Company (SHW) Ecolab Inc. (ECL)